Anti-cancer effects of the Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo

The study elucidate the anti-cancer effects of Erzhimaoling decoction (EZMLD) in high-grade serous ovarian cancer (HGSOC) cells.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-22
DOI
https://doi.org/10.5281/zenodo.8370247
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-cancer effects of the Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo

Zenodo (CERN European Organization for Nuclear Research)
Traditional Chinese Medicine Analysis
article

Anti-cancer effects of the Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo

article en

Abstract

The study elucidate the anti-cancer effects of Erzhimaoling decoction (EZMLD) in high-grade serous ovarian cancer (HGSOC) cells.

Zenodo (CERN European Organization for Nuclear Research)
Zhejiang Chinese Medical University (CN), Zhejiang Cancer Hospital (CN), CM Hospital (KR)
Good health and well-being
Openalex Percentile: Top 45%
Traditional Chinese Medicine Analysis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anti-cancer effects of the Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS